Relative bioavailability of 21-desacetyldeflazacort after oral administration of various deflazacort formulations and dosing conditions in healthy volunteer subjects

Wanaski S.; Brantley S.; Grasfeder L.; Dubow J.; Beers B.; Kernbauer E.; Wells C.; Cunniff T.

首页> 外文期刊>Neuromuscular disorders: NMD >Relative bioavailability of 21-desacetyldeflazacort after oral administration of various deflazacort formulations and dosing conditions in healthy volunteer subjects

【24h】

Relative bioavailability of 21-desacetyldeflazacort after oral administration of various deflazacort formulations and dosing conditions in healthy volunteer subjects

机译：在健康志愿者受试者中口服各种脱黄皮质激素制剂和给药条件后21-脱乙酰基脱黄皮质激素的相对生物利用度

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuromuscular disorders: NMD》 |2016年第2期|共1页
作者
Wanaski S.; Brantley S.; Grasfeder L.; Dubow J.; Beers B.; Kernbauer E.; Wells C.; Cunniff T.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Relative bioavailability of 21-desacetyldeflazacort after oral administration of various deflazacort formulations and dosing conditions in healthy volunteer subjects [J] . Wanaski S., Brantley S., Grasfeder L., Neuromuscular disorders: NMD . 2016,第Suppla2期

机译：在健康志愿者受试者中口服各种脱黄皮质激素制剂和给药条件后21-脱乙酰基脱黄皮质激素的相对生物利用度
2. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers [J] . Antonio Rusca, Andrea Francesco Daniele Di Stefano, Mira V. Doig, European Journal of Clinical Pharmacology . 2009,第5期

机译：健康志愿者多剂量给药后二十二碳六烯酸/二十碳五烯酸的两种口服制剂的相对生物利用度和药代动力学
3. Single‐Dose Pharmacokinetic Properties and Relative Bioavailability of Different Formulations of Posaconazole Oral Suspension in Healthy Volunteers [J] . Vuleti? Lucija, Herceg Marina, Ferderber Kristina, Clinical pharmacology in drug development . 2019,第6期

机译：在健康志愿者中不同配方的单剂量药代动力学特性及不同配方的相对生物利用度
4. ORAL BIOAVAILABILITY OF DN-101, A NEW FORMULATION OF HIGHLY CONCENTRATED CALCITRIOL, AFTER ADMINISTRATION OF A SINGLE DOSE TO DOGS [C] . Kenneth M. Rassnick, Josephia R. Muindi, Dennis B. Bailey, Annual conference of the Veterinary Cancer Society . 2008

机译：DN-101的口服生物利用度，高度浓缩钙质的新配方，在给狗的单剂量施用后
5. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine, bioavailability and bioequivalence of verapamil HCL controlled release formulations, pharmacokinetics of terbinafine after single oral doses in raptors. [D] . Fahmy, Sahar Abd El-Sattar. 2004

机译：硝苯地平新型喷雾包衣的软弹性明胶胶囊缓释制剂的开发，维拉帕米盐酸盐控释制剂的生物利用度和生物等效性，在猛禽中单次口服剂量后特比萘芬的药代动力学。
6. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions [O] . Sophie Boudriau, Cecilia Hanzel, Julie Massicotte, 2016

机译：在空腹和进食条件下向健康人类志愿者施用单次1000 mg剂量的左乙拉西坦的新型三维印刷快熔配方的随机比较生物利用度
7. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions [O] . Sophie Boudriau, Cecilia Hanzel, Julie Massicotte, 2016

机译：在空腹和进食条件下向健康人类志愿者服用单次1000毫克剂量的左乙拉西坦的新型三维印刷快熔配方的随机比较生物利用度

Relative bioavailability of 21-desacetyldeflazacort after oral administration of various deflazacort formulations and dosing conditions in healthy volunteer subjects

著录项

相似文献

相关主题

期刊订阅